The Office for Product Safety and Standards (OPSS) has established a safety study to understand the risks presented by e-bikes and e-scooters. This includes understanding available data, investigating incidents, enforcement action when needed, targeting unsafe products at the border, and providing public safety information on safe use and charging.<\/p>
<\/p>
OPSS commissioned Warwick Manufacturing Group, part of Warwick University, to conduct research examining the safety of the lithium-ion batteries within Personal Light Electric Vehicles.<\/p>
<\/p>
These activities form part of cross Government work involving the Home Office, Department for Transport and OPSS, which is part of the Department for Business and Trade.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4474", "label" : {"_value" : "Biography information for Kevin Hollinrake"} } , "answeringMemberConstituency" : {"_value" : "Thirsk and Malton"} , "answeringMemberPrinted" : {"_value" : "Kevin Hollinrake"} , "dateOfAnswer" : {"_value" : "2023-07-19", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2023-07-19T09:10:50.95Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "214"} , "answeringDeptShortName" : {"_value" : "Business and Trade"} , "answeringDeptSortName" : {"_value" : "Business and Trade"} , "date" : {"_value" : "2023-07-12", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Electric Scooters: Batteries"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Business and Trade, what assessment she has made of the seriousness of the fire risk posed by lithium batteries in e-scooters.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4382", "label" : {"_value" : "Biography information for Daniel Zeichner"} } , "tablingMemberConstituency" : {"_value" : "Cambridge"} , "tablingMemberPrinted" : [{"_value" : "Daniel Zeichner"} ], "uin" : "193664"} , {"_about" : "http://data.parliament.uk/resources/1652540", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1652540/answer", "answerText" : {"_value" : "
Before December 2021, applicants were required to respond to all requests from the Medicines and Healthcare products Regulatory Agency for further information (also known as \u2018grounds for non-acceptance\u2019) within 14 days. However, since December 2021, applicants have had the flexibility to request additional time to respond to requests for further information, as required, by contacting the Clinical Trials Helpline.<\/p>
Furthermore, as stated in the Government response to the Consultation on legislative proposals for clinical trials (published 21 March 2023), we will introduce a 60-day timeframe (with flexible extension) to respond to any requests for further information. This flexibility will enable sponsors to prepare robust responses and interact with assessors to satisfy the regulators and avoid application rejections. It is important to note that the 60-day proposal is a maximum timeframe, so the sponsor could respond as quickly as they would like up to this limit.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4423", "label" : {"_value" : "Biography information for Will Quince"} } , "answeringMemberConstituency" : {"_value" : "Colchester"} , "answeringMemberPrinted" : {"_value" : "Will Quince"} , "dateOfAnswer" : {"_value" : "2023-07-19", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2023-07-19T09:48:24.947Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2023-07-12", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Medicines and Healthcare products Regulatory Agency: Standards"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, whether he has made an assessment of the adequacy of the Medicines and Healthcare products Regulatory Agency on the adequacy of response times to requests for further information on clinical trials.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4382", "label" : {"_value" : "Biography information for Daniel Zeichner"} } , "tablingMemberConstituency" : {"_value" : "Cambridge"} , "tablingMemberPrinted" : [{"_value" : "Daniel Zeichner"} ], "uin" : "193791"} , {"_about" : "http://data.parliament.uk/resources/1650821", "AnsweringBody" : [{"_value" : "Department for Environment, Food and Rural Affairs"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1650821/answer", "answerText" : {"_value" : "
Avian influenza, once introduced into a premises, spreads rapidly through birds present. As set out in the Notifiable Avian Disease Control Strategy for Great Britain<\/a> swift and humane culling of poultry and other captive birds on infected premises coupled with good biosecurity is used to prevent the amplification of avian influenza and subsequent environmental contamination, reduce the risk of disease spread from infected premises and mitigate any public health risk these infected birds may pose. Defra\u2019s disease control measures seek to contain the number of animals that need to be culled, either for disease control purposes or to safeguard animal welfare. Current policy reflects our experience of responding to past outbreaks of exotic animal disease and is in line with international standards of best practice for disease control.<\/p> During the 2022/23 outbreak 5.4 million birds have died or been culled and disposed for disease control purposes, a small proportion of overall poultry production (c.20m birds slaughtered for human consumption per week).<\/p> At each infected premises the Animal and Plant Health Agency (APHA) carry out veterinary investigations to identify, as far as possible the likely source of infection, and establish how long the disease may have been present on the infected premises together with identifying and investigating potential routes of spread from the premises. We have recently published the 2021/22 highly pathogenic avian influenza outbreak <\/a> which provides a summary of the outcomes of these investigations. The report for 2022/23 will be published in due course.<\/p> Epidemiological investigations to date show that the introduction of infection to poultry premises is almost entirely by direct or indirect spread from wild birds and that there has been no transmission between poultry premises apart from where they are located close together and are part of the same integrated company or business, and share staff and equipment. Key findings from these investigations help drive assessment and improvements in biosecurity best practice on poultry and other captive bird premises.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4055", "label" : {"_value" : "Biography information for Sir Mark Spencer"}
}
, "answeringMemberConstituency" : {"_value" : "Sherwood"}
, "answeringMemberPrinted" : {"_value" : "Mark Spencer"}
, "dateOfAnswer" : {"_value" : "2023-07-17", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : {"_value" : "192821"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2023-07-17T15:26:28.05Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "13"}
, "answeringDeptShortName" : {"_value" : "Environment, Food and Rural Affairs"}
, "answeringDeptSortName" : {"_value" : "Environment, Food and Rural Affairs"}
, "date" : {"_value" : "2023-07-06", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Avian Influenza: Disease Control"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Environment, Food and Rural Affairs, what assessment she has made of the value for money provided by the flock depopulation measures carried out by the Animal and Plant Health Agency during the 2022-23 outbreak of avian influenza.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4382", "label" : {"_value" : "Biography information for Daniel Zeichner"}
}
, "tablingMemberConstituency" : {"_value" : "Cambridge"}
, "tablingMemberPrinted" : [{"_value" : "Daniel Zeichner"}
], "uin" : "192820"}
, {"_about" : "http://data.parliament.uk/resources/1650826", "AnsweringBody" : [{"_value" : "Department for Environment, Food and Rural Affairs"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1650826/answer", "answerText" : {"_value" : "